Ahmedabad, India

Bakulesh Mafatlal Khamar

This inventor holds 19 USPTO granted patents and 10 published patent applications, plus 8 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Cadila Pharmaceuticals Limited, Cadila Corporate Campus. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bakulesh Mafatlal Khamar. Retrieved from https://idiyas.com/inventor/bakulesh-mafatlal-khamar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 52.6

 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Gujarat, IN (2011 - 2021)
  • Ahmedabad, IN (2001 - 2022)

Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Therapeutic Cancer Vaccine
Pharmaceutical Composition
Atherosclerosis
Vaccine Adjuvants
Curcumin
HIV Treatment
Hypoglycemic Compounds
Cancer Antigen
Farnesoid-X-Receptor Antagonist
Dipeptidyl Peptidase IV
Taxoids
Poly TLR Antagonist
19 patents (USPTO):Explore Patents

Title: Innovations by Bakulesh Mafatlal Khamar

Introduction

Bakulesh Mafatlal Khamar is a prominent inventor based in Ahmedabad, India. With an impressive portfolio of 19 patents, he has made significant contributions to the fields of therapeutic vaccines and pharmaceuticals.

Latest Patents

One of his remarkable inventions is a therapeutic cancer vaccine. This innovative vaccine comprises cancer cells expressing antigens and excipients, optionally including an adjuvant. The vaccine is designed to induce a specific immune response against homologous and heterologous cancer cells within tissues or organs. He has also developed a method for preparing this vaccine composition.

Additionally, Bakulesh has patented novel intermediates for the synthesis of Rivastigmine, a medication used in the treatment of Alzheimer's disease. This patent details the processes for preparing such intermediates, which are crucial for the efficient production of Rivastigmine and its pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Bakulesh has worked with prestigious organizations, notably Cadila Pharmaceuticals Limited and Cadila Corporate Campus. His contributions in these companies have significantly advanced the development of innovative healthcare solutions.

Collaborations

Bakulesh has collaborated with esteemed professionals in the industry, including Indravadan Ambalal Modi and Rajiv Indravadan Modi. Their teamwork has further propelled the advancement of innovative medical treatments and formulations.

Conclusion

Bakulesh Mafatlal Khamar's dedication to innovation in the pharmaceutical field is evident through his extensive patent portfolio and collaborative efforts. His inventions not only pave the way for advancements in cancer treatment but also improve the pharmaceutical manufacturing process, showcasing the impact of his work on global healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…